Industrial studies

MOLECULE SPONSOR Acronym PHASE STUDY TITLE LINK
Apomorphine / device ORKYN OPTIPARK 2.0 NA Use an Actimetry procedure during initiation of treatment with apomorphine delivered by a pump in patients with Parkinson's disease  
APL-130277 SUNOVION   III An Open-Label, Randomized, Crossover Trial utilizing a Single-Blinded Rater to evaluate APL-130277 compared to s.c. Apomorphine in Levodopa Responsive Subjects with Parkinson’s Disease Complicated by Motor Fluctuations ¤
Bumetanide  B&A Therapeutics Curepark II Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease  ¤
Safinamide Zambon   III A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Safinamide 100 mg once daily, as add-on therapy, in Idiopathic Parkinson’s Disease (PD) patients with motor  ¤
Verdiperstat BIOHAVEN M-STAR III A randomized, double-blind, placebo-controlled,parallel-group study to evaluate the efficacy and safety of BHV-3241 in subjects with Multiple System Atrophy  ¤
English